AmEx recalls eye treatments after FDA concerns

After an FDA inspection, AmEx Pharmacy is recalling all lots of two of its bevacizumab injectables,  used to treat macular degeneration and diabetic retinopathy.

The affected products, bevacizumab injectable and bevacizumab normject TB injectable, were distributed to 38 states, Washington, D.C., and Puerto Rico.

The pharmacy is recalling all lots of the products due to concerns over a lack of sterility. The FDA issued a formal request in late August to AmEx Pharmacy to recall all of its compounded drug products intended to be sterile after the company failed to take corrective actions when  an inspection found "significant quality and sterility concerns."

The pharmacy is notifying its customers and arranging for the return of all recalled products.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars